Europe Dermal Fillers Market Research Research Report

List of Tables

Europe Dermal Fillers Market Research Report Forecast to 2032

Market Overview

Dermal filler is a gel-like substance that is injected underneath the skin to restore lost volume, often creases and smooth lines or enhance facial contours. Dermal fillers usage has rapidly grown in recent years because of various offerings in the enhancing aesthetic and rejuvenate improvements that were previously only achievable with surgeries. These are becoming very popular for facial rejuvenation methods. Being minimally invasive dermal filler shows instantaneous results in cosmetic volume replacement therapies.

Dermal fillers can be defined as soft tissue fillers injected into the skin for the restoration of smooth appearance and the reduction of wrinkles and other signs of the aging process. The rapidly expanding range of dermal filler products and their increased benefits are fueling the preference rates of dermal fillers among medical professionals as well as patients. The growing demand for facial aesthetics, increasing inclination towards the use of dermal fillers, a rise in the number of plastic surgeons performing cosmetic surgeries, and the decreased procedural cost of dermal fillers in comparison to the cosmetic surgeries are driving the dermal fillers market. However, the side-effects associated with such facial injectables, coupled with the increasing black market for dermal fillers, and emergence of COVID-19 coronavirus is likely to curb the growth of the dermal fillers market. Nevertheless, the rise in the number of clinical trial studies for increasing efficiency rates of dermal fillers will create lucrative opportunities for the growth of the market during the assessment period.

Market Segmentation

Based on type, the Europe dermal fillers market has been segmented into botulinum toxin, calcium hydroxylapatite, hyaluronic acid, polyalkylimide, poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA), and others.

Based on product, the Europe dermal fillers market has been segmented into biodegradable, non-biodegradable, synthetic neurotoxins.

On the basis of application, the Europe dermal fillers market has been segmented into facial line correction, face lift, lip enhancement, facial scars, nasolabial folds, and others.

Based on country, the Europe dermal filler market has been segmented into Germany, France, UK, Italy, Spain, Denmark, Finland, Iceland, Norway, Sweden, and Rest of Europe. Germany accounted for the largest market share in 2022. However, France is projected to grow at fastest growing during the forecast period.

Major Players

The key market players are Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Ipsen SA (Ipsen), ADODERM GmbH, BioScience GmbH, Allergan Inc. (Allergan), Galderma develops aesthetics, Teoxane, Dr. Korman, and Medytox.

1EXECUTIVE SUMMARY

2MARKET INTRODUCTION

2.1DEFINITION
2.2SCOPE OF THE STUDY
2.3RESEARCH OBJECTIVE
2.4MARKET STRUCTURE

3RESEARCH METHODOLOGY

3.1OVERVIEW
3.2DATA FLOW
- 3.2.1Data Mining Process
3.3PURCHASED DATABASE:
3.4SECONDARY SOURCES:
- 3.4.1Secondary Research data flow:
3.5PRIMARY RESEARCH:
- 3.5.1Primary Research DATA FLOW:
- 3.5.2Primary Research: Number of Interviews conducted
3.6APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1Revenue Analysis Approach
3.7DATA FORECASTING
- 3.7.1Data forecasting Technique
3.8DATA MODELLING
- 3.8.1microeconomic factor analysis:
- 3.8.2Data Modelling:
3.9TEAMS AND ANALYST CONTRIBUTION

4MARKET DYNAMICS

4.1INTRODUCTION
4.2DRIVERS
- 4.2.1GROWING DEMAND FOR FACIAL AESTHETICS
- 4.2.2INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS
- 4.2.3Rapid advancements in technology
4.3RESTRAINTS
- 4.3.1SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS
4.4OPPORTUNITY
- 4.4.1RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES

5MARKET FACTOR ANALYSIS

5.1PORTER'S FIVE FORCES MODEL
- 5.1.1Threat of New Entrants
- 5.1.2Bargaining Power of Suppliers
- 5.1.3Threat of Substitutes
- 5.1.4Bargaining Power of Buyers
- 5.1.5Intensity of Rivalry
5.2IMPACT OF COVID-19 ON THE EUROPE DERMAL FILLERS MARKET
- 5.2.1impact on supply chain
- 5.2.2IMPACT ON KEY PLAYERS
5.3NUMBER OF DERMAL FILLER PROCEDURES, BY COUNTRY- 2019-2032
5.4TOTAL NUMBER OF PRIVATE DERMATOLOGY CLINICS, BY COUNTRY (2022)

6EUROPE DERMAL FILLERS MARKET, BY TYPE

6.1OVERVIEW
6.2BOTULINUM TOXIN
6.3CALCIUM HYDROXYLAPATITE
6.4HYALURONIC ACID
6.5POLY-L-LACTIC ACID
6.6POLYALKYLIMIDE
6.7POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
6.8OTHERS

7EUROPE DERMAL FILLERS MARKET, BY PRODUCT

7.1OVERVIEW
7.2BIODEGRADABLE
7.3NON-BIODEGRADABLE
7.4SYNTHETIC NEUROTOXIN

8EUROPE DERMAL FILLERS MARKET, BY APPLICATION

8.1OVERVIEW
8.2FACIAL LINE CORRECTION
8.3FACE LIFT
8.4LIP ENHANCEMENT
8.5FACIAL SCARS
8.6NASOLABIAL FOLDS
8.7OTHERS

9EUROPE DERMAL FILLERS MARKET, BY COUNTRY

9.1OVERVIEW
9.2EUROPE
- 9.2.1Germany
- 9.2.2France
- 9.2.3United Kingdom
- 9.2.4Spain
- 9.2.5Italy
- 9.2.6Denmark
- 9.2.7Finland
- 9.2.8Iceland
- 9.2.9Norway
- 9.2.10Sweden
- 9.2.11Rest of Europe

10COMPETITIVE LANDSCAPE

10.1INTRODUCTION
10.2COMPETITOR DASHBOARD
10.3KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.3.1product launch
- 10.3.2Agreement launch

11COMPANY PROFILES

11.1IPSEN SA
- 11.1.1COMPANY OVERVIEW
- 11.1.2FINANCIAL OVERVIEW
- 11.1.3PRODUCTS OFFERED
- 11.1.4KEY DEVELOPMENTS
- 11.1.5SWOT ANALYSIS
- 11.1.6KEY STRATEGIES
11.2ADODERM GMBH
- 11.2.1COMPANY OVERVIEW
- 11.2.2FINANCIAL OVERVIEW
- 11.2.3PRODUCTS OFFERED
- 11.2.4KEY DEVELOPMENTS
- 11.2.5KEY STRATEGIES
11.3BIOSCIENCE GMBH
- 11.3.1COMPANY OVERVIEW
- 11.3.2FINANCIAL OVERVIEW
- 11.3.3PRODUCTS OFFERED
- 11.3.4KEY DEVELOPMENTS
- 11.3.5KEY STRATEGIES
11.4ALLERGAN, INC.
- 11.4.1COMPANY OVERVIEW
- 11.4.2FINANCIAL OVERVIEW
- 11.4.3Products OFFERed
- 11.4.4KEY DEVELOPMENTS
- 11.4.5SWOT ANALYSIS
- 11.4.6Key Strategy
11.5MERZ PHARMA GMBH & CO. KGAA
- 11.5.1COMPANY OVERVIEW
- 11.5.2FINANCIAL OVERVIEW
- 11.5.3PRODUCTS OFFERED
- 11.5.4KEY DEVELOPMENTS
- 11.5.5SWOT ANALYSIS
- 11.5.6KEY STRATEGIES
11.6GALDERMA
- 11.6.1COMPANY OVERVIEW
- 11.6.2FINANCIAL OVERVIEW
- 11.6.3PRODUCTS OFFERED
- 11.6.4KEY DEVELOPMENTS
- 11.6.5SWOT ANALYSIS
- 11.6.6KEY STRATEGIES
11.7SINCLAIR PHARMA
- 11.7.1COMPANY OVERVIEW
- 11.7.2FINANCIAL OVERVIEW
- 11.7.3PRODUCTS OFFERED
- 11.7.4KEY DEVELOPMENTS
- 11.7.5KEY STRATEGIES
11.8TEOXANE
- 11.8.1COMPANY OVERVIEW
- 11.8.2FINANCIAL OVERVIEW
- 11.8.3productS OFFERED
- 11.8.4KEY DEVELOPMENTS
- 11.8.5KEY STRATEGIES
11.9DR. KORMAN
- 11.9.1COMPANY OVERVIEW
- 11.9.2FINANCIAL OVERVIEW
- 11.9.3products OFFERED
- 11.9.4KEY DEVELOPMENTS
- 11.9.5KEY STRATEGIES
11.10MEDYTOX
- 11.10.1COMPANY OVERVIEW
- 11.10.2FINANCIAL OVERVIEW
- 11.10.3productS OFFERED
- 11.10.4KEY DEVELOPMENTSs
- 11.10.5SWOT ANALYSIS
- 11.10.6KEY STRATEGIES

12DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT 32
TABLE 2 NUMBER OF DERMAL FILLER PROCEDURES, BY COUNTRY- 2019-2032 45
TABLE 3 TOTAL NUMBER OF PRIVATE DERMATOLOGY CLINICS, BY COUNTRY (2022) 45
TABLE 4 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (USD MILLION) 49
TABLE 5 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2019-2032 (NUMBER IN VOLUME) 49
TABLE 6 EUROPE DERMAL FILLERS MARKET, FOR BOTULINUM TOXIN, BY COUNTRY, 2019-2032 (USD MILLION) 50
TABLE 7 EUROPE DERMAL FILLERS MARKET, FOR BOTULINUM TOXIN, BY COUNTRY, 2019-2032 (NUMBER OF PROCEDURE) 51
TABLE 8 EUROPE DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY COUNTRY, 2019-2032 (USD MILLION) 52
TABLE 9 EUROPE DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY COUNTRY, 2019-2032 (NUMBER OF PROCEDURE) 53
TABLE 10 EUROPE DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY COUNTRY, 2019-2032 (USD MILLION) 54
TABLE 11 EUROPE DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY COUNTRY, 2019-2032 (N NUMBER OF PROCEDURE) 55
TABLE 12 EUROPE DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY COUNTRY, 2019-2032 (USD MILLION) 56
TABLE 13 EUROPE DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY COUNTRY, 2019-2032 (N NUMBER OF PROCEDURE) 57
TABLE 14 EUROPE DERMAL FILLERS MARKET, FOR POLYALKYLIMIDE, BY COUNTRY, 2019-2032 (USD MILLION) 58
TABLE 15 EUROPE DERMAL FILLERS MARKET, FOR POLYALKYLIMIDE, BY COUNTRY, 2019-2032 (N NUMBER OF PROCEDURE) 59
TABLE 16 EUROPE DERMAL FILLERS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY COUNTRY, 2019-2032 (USD MILLION) 60
TABLE 17 EUROPE DERMAL FILLERS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY COUNTRY, 2019-2032 (NUMBER OF PROCEDURE) 61
TABLE 18 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (USD MILLION) 62
TABLE 19 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (NUMBER OF PROCEDURE) 63
TABLE 20 EUROPE DERMAL FILLERS MARKET, BY PRODUCT, 2019-2032 (USD MILLION) 65
TABLE 21 EUROPE DERMAL FILLERS MARKET, FOR BIODEGRADABLE, BY COUNTRY, 2019-2032 (USD MILLION) 66
TABLE 22 EUROPE DERMAL FILLERS MARKET, FOR NON-BIODEGRADABLE, BY COUNTRY, 2019-2032 (USD MILLION) 67
TABLE 23 EUROPE DERMAL FILLERS MARKET, FOR SYNTHETIC NEUROTOXIN, BY COUNTRY, 2019-2032 (USD MILLION) 68
TABLE 24 EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 71
TABLE 25 EUROPE DERMAL FILLERS MARKET, FOR FACIAL LINE CORRECTION, BY COUNTRY, 2019-2032 (USD MILLION) 72
TABLE 26 EUROPE DERMAL FILLERS MARKET, FOR FACE LIFT, BY COUNTRY, 2019-2032 (USD MILLION) 73
TABLE 27 EUROPE DERMAL FILLERS MARKET, FOR LIP ENHANCEMENT, BY COUNTRY, 2019-2032 (USD MILLION) 74
TABLE 28 EUROPE DERMAL FILLERS MARKET, FOR FACIAL SCARS, BY COUNTRY, 2019-2032 (USD MILLION) 75
TABLE 29 EUROPE DERMAL FILLERS MARKET, FOR NASOLABIAL FOLDS, BY COUNTRY, 2019-2032 (USD MILLION) 76
TABLE 30 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (USD MILLION) 77
TABLE 31 EUROPE: EUROPE DERMAL FILLERS MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 80
TABLE 32 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 81
TABLE 33 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 81
TABLE 34 GERMANY: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 81
TABLE 35 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 82
TABLE 36 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 82
TABLE 37 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 83
TABLE 38 FRANCE: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 83
TABLE 39 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 83
TABLE 40 UNITED KINGDOM: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 84
TABLE 41 UNITED KINGDOM: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 84
TABLE 42 UNITED KINGDOM: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 84
TABLE 43 UNITED KINGDOM: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 85
TABLE 44 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 85
TABLE 45 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 86
TABLE 46 SPAIN: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 86
TABLE 47 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 86
TABLE 48 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 87
TABLE 49 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 87
TABLE 50 ITALY: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 87
TABLE 51 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 88
TABLE 52 DENMARK: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 88
TABLE 53 DENMARK: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 89
TABLE 54 DENMARK: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 89
TABLE 55 DENMARK: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 89
TABLE 56 FINLAND: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 90
TABLE 57 FINLAND: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 90
TABLE 58 FINLAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 90
TABLE 59 FINLAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 91
TABLE 60 ICELAND: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 91
TABLE 61 ICELAND: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 91
TABLE 62 ICELAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 92
TABLE 63 ICELAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 92
TABLE 64 NORWAY: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 93
TABLE 65 NORWAY: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 93
TABLE 66 NORWAY: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 94
TABLE 67 NORWAY: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 94
TABLE 68 SWEDEN: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 95
TABLE 69 SWEDEN: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 96
TABLE 70 SWEDEN: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 96
TABLE 71 SWEDEN: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 96
TABLE 72 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (USD MILLION) 97
TABLE 73 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019-2030 (NUMBER OF PROCEDURES) 97
TABLE 74 REST OF EUROPE: DERMAL FILLERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 97
TABLE 75 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 98
TABLE 76 PRODUCT LAUNCH 102
TABLE 77 AGREEMENT LAUNCH 102
TABLE 78 IPSEN SA : PRODUCTS OFFERED 104
TABLE 79 IPSEN SA : SWOT ANALYSIS 105
TABLE 80 ADODERM GMBH: PRODUCTS OFFERED 107
TABLE 81 BIOSCIENCE GMBH: PRODCUTS OFFERED 109
TABLE 82 ALLERGAN, INC.: PRODUCTS OFFERED 111
TABLE 83 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS OFFERED 114
TABLE 84 MERZ PHARMA GMBH & CO. KGAA: KEY DEVELOPMENTS 114
TABLE 85 GALDERMA: PRODCUTS OFFERED 117
TABLE 86 SINCLAIR PHARMA: PRODUCTS OFFERED 120
TABLE 87 SINCLAIR PHARMA: KEY DEVELOPMENTS 120
TABLE 88 TEOXANE: PRODUCT OFFERED 122
TABLE 89 DR. KORMAN: PRODUCT OFFERED 124
TABLE 90 MEDYTOX: PRODUCT OFFERED 126

LIST OF FIGURES

FIGURE 1EUROPE DERMAL FILLER MARKET: STRUCTURE19
FIGURE 2EUROPE DERMAL FILLERSMARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)36
FIGURE 3DRIVER IMPACT ANALYSIS (2023-2032)38
FIGURE 4RESTRAINT IMPACT ANALYSIS (2022-2032)39
FIGURE 5PORTER'S FIVE FORCES ANALYSIS: EUROPE DERMAL FILLERS MARKET42
FIGURE 6EUROPE DERMAL FILLERS MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)48
FIGURE 7EUROPE DERMAL FILLERS MARKET, BY TYPE, 2022 & 2032 (USD MILLION)48
FIGURE 8EUROPE DERMAL FILLERS MARKET SHARE (%), BY TYPE, 202250
FIGURE 9EUROPE DERMAL FILLERS MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)64
FIGURE 10EUROPE DERMAL FILLERS MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)65
FIGURE 11EUROPE DERMAL FILLERS MARKET SHARE (%), BY PRODUCT, 202265
FIGURE 12EUROPE DERMAL FILLERS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)70
FIGURE 13EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)70
FIGURE 14EUROPE DERMAL FILLERS MARKET SHARE (%), BY APPLICATION, 202271
FIGURE 15EUROPE MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD MILLION)79
FIGURE 16EUROPE: EUROPE DERMAL FILLERS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)79
FIGURE 17EUROPE: EUROPE DERMAL FILLERS MARKET SHARE (%), BY COUNTRY, 202280
FIGURE 18COMPETITOR DASHBOARD: EUROPE DERMAL FILLERS MARKET101
FIGURE 19IPSEN SA : FINANCIAL OVERVIEW SNAPSHOT104
FIGURE 20ALLERGAN, INC.: SWOT ANALYSIS112
FIGURE 21MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS115
FIGURE 22GALDERMA: SWOT ANALYSIS118
FIGURE 23MEDYTOX: SWOT ANALYSIS127

Europe Dermal Fillers Market Research Research Report - Forecast to 2032

Description

Table of Contents